[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623575":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":183,"collaborators":26,"id":185,"slug":186,"hasResults":187,"nctId":188,"briefTitle":189,"officialTitle":190,"acronym":191,"eligibilityCriteria":192,"healthyVolunteers":187,"sex":193,"minAge":194,"maxAge":26,"enrollmentInfo":195,"targetDuration":26,"studyType":198,"phases":199,"briefSummary":201,"conditions":202,"keywords":204,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":214,"lastUpdatePostDateStruct":215,"startDateStruct":218,"completionDateStruct":220,"leadSponsor":222,"locationsCount":223},{"fullName":5,"class":6},"Axsome Therapeutics, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"AXS-14 (esreboxetine)","EXPERIMENTAL","* Up to 12 weeks in the open-label period;\n* Up to 12 weeks in the randomized double-blind period (if applicable)",[13],"Drug: AXS-14 (Esreboxetine)",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","• Up to 12 weeks in the randomized double-blind period (if applicable)",[19],"Drug: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","AXS-14 (Esreboxetine)","AXS-14 tablets taken once daily",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Placebo tablets taken once daily",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Study Director","CONTACT","212-332-5061","AXS-14-FM-301@axsome.com",[37,51,60,69,78,86,94,103,112,121,130,139,147,156,165,174],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":26},"Clinical Research Site","RECRUITING","Little Rock","Arkansas","72211","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-92.28959,34.74648,{"lat":49,"lon":48},{"facility":38,"status":39,"city":52,"state":53,"zip":54,"country":43,"countryCode":44,"cosmosGeoPoint":55,"geoPoint":59,"contacts":26},"Santa Ana","California","92705",{"type":46,"coordinates":56},[57,58],-117.86783,33.74557,{"lat":58,"lon":57},{"facility":38,"status":39,"city":61,"state":62,"zip":63,"country":43,"countryCode":44,"cosmosGeoPoint":64,"geoPoint":68,"contacts":26},"Cromwell","Connecticut","06416",{"type":46,"coordinates":65},[66,67],-72.64537,41.5951,{"lat":67,"lon":66},{"facility":38,"status":39,"city":70,"state":71,"zip":72,"country":43,"countryCode":44,"cosmosGeoPoint":73,"geoPoint":77,"contacts":26},"Jacksonville","Florida","32256",{"type":46,"coordinates":74},[75,76],-81.65565,30.33218,{"lat":76,"lon":75},{"facility":38,"status":39,"city":79,"state":71,"zip":80,"country":43,"countryCode":44,"cosmosGeoPoint":81,"geoPoint":85,"contacts":26},"Orlando","32801",{"type":46,"coordinates":82},[83,84],-81.37924,28.53834,{"lat":84,"lon":83},{"facility":38,"status":39,"city":87,"state":71,"zip":88,"country":43,"countryCode":44,"cosmosGeoPoint":89,"geoPoint":93,"contacts":26},"Tampa","33634",{"type":46,"coordinates":90},[91,92],-82.45843,27.94752,{"lat":92,"lon":91},{"facility":38,"status":39,"city":95,"state":96,"zip":97,"country":43,"countryCode":44,"cosmosGeoPoint":98,"geoPoint":102,"contacts":26},"Atlanta","Georgia","30329",{"type":46,"coordinates":99},[100,101],-84.38798,33.749,{"lat":101,"lon":100},{"facility":38,"status":39,"city":104,"state":105,"zip":106,"country":43,"countryCode":44,"cosmosGeoPoint":107,"geoPoint":111,"contacts":26},"Overland Park","Kansas","66209",{"type":46,"coordinates":108},[109,110],-94.67079,38.98223,{"lat":110,"lon":109},{"facility":38,"status":39,"city":113,"state":114,"zip":115,"country":43,"countryCode":44,"cosmosGeoPoint":116,"geoPoint":120,"contacts":26},"Louisville","Kentucky","40205",{"type":46,"coordinates":117},[118,119],-85.75941,38.25424,{"lat":119,"lon":118},{"facility":38,"status":39,"city":122,"state":123,"zip":124,"country":43,"countryCode":44,"cosmosGeoPoint":125,"geoPoint":129,"contacts":26},"Prairieville","Louisiana","70769",{"type":46,"coordinates":126},[127,128],-90.97205,30.30297,{"lat":128,"lon":127},{"facility":38,"status":39,"city":131,"state":132,"zip":133,"country":43,"countryCode":44,"cosmosGeoPoint":134,"geoPoint":138,"contacts":26},"Springfield","Missouri","65807",{"type":46,"coordinates":135},[136,137],-93.29824,37.21533,{"lat":137,"lon":136},{"facility":38,"status":39,"city":140,"state":132,"zip":141,"country":43,"countryCode":44,"cosmosGeoPoint":142,"geoPoint":146,"contacts":26},"Town and Country","63017",{"type":46,"coordinates":143},[144,145],-90.46345,38.61228,{"lat":145,"lon":144},{"facility":38,"status":39,"city":148,"state":149,"zip":150,"country":43,"countryCode":44,"cosmosGeoPoint":151,"geoPoint":155,"contacts":26},"Tulsa","Oklahoma","74133",{"type":46,"coordinates":152},[153,154],-95.99277,36.15398,{"lat":154,"lon":153},{"facility":38,"status":39,"city":157,"state":158,"zip":159,"country":43,"countryCode":44,"cosmosGeoPoint":160,"geoPoint":164,"contacts":26},"Charleston","South Carolina","29407",{"type":46,"coordinates":161},[162,163],-79.93275,32.77632,{"lat":163,"lon":162},{"facility":38,"status":39,"city":166,"state":167,"zip":168,"country":43,"countryCode":44,"cosmosGeoPoint":169,"geoPoint":173,"contacts":26},"Memphis","Tennessee","38119",{"type":46,"coordinates":170},[171,172],-90.04898,35.14953,{"lat":172,"lon":171},{"facility":38,"status":39,"city":175,"state":176,"zip":177,"country":43,"countryCode":44,"cosmosGeoPoint":178,"geoPoint":182,"contacts":26},"Prosper","Texas","75078",{"type":46,"coordinates":179},[180,181],-96.80111,33.23623,{"lat":181,"lon":180},{"type":184,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100623575","phase-3-fibromyalgia-response-with-esreboxetine-evaluated-using-a-randomized-withdrawal-research-design-100623575",false,"NCT07398417","Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design","A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia","FORWARD","Inclusion Criteria:\n\n* Has a primary diagnosis of fibromyalgia based on the 2016 ACR diagnostic criteria.\n* Male or female, ≥18 years of age.\n* Provides written informed consent to participate in the study before conducting any study procedures.\n\nExclusion Criteria:\n\n* Previous participation in a clinical trial with reboxetine or esreboxetine or currently receiving treatment with reboxetine for any condition.\n* Unable to comply with study procedures.\n* Medically inappropriate for study participation in the opinion of the investigator.","ALL","18 Years",{"count":196,"type":197},620,"ESTIMATED","INTERVENTIONAL",[200],"PHASE3","The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.",[203],"Fibromyalgia",[203,205,206,207,208,209,210,211,212,213],"Central Sensitization","Allodynia","Hyperalgesia","Hypersensitivity to sensory stimuli","Inhibitor of the norepinephrine transporter (NET)","Esreboxetine","AXS-14","Axsome","Norepinephrine reuptake inhibitor","2026-02-04",{"date":216,"type":217},"2026-02-09","ACTUAL",{"date":219,"type":217},"2026-01-14",{"date":221,"type":197},"2028-03",{"name":5,"class":6},16]